470 related articles for article (PubMed ID: 24126807)
1. Vascularized composite allografts and solid organ transplants: similarities and differences.
Weissenbacher A; Hautz T; Pratschke J; Schneeberger S
Curr Opin Organ Transplant; 2013 Dec; 18(6):640-4. PubMed ID: 24126807
[TBL] [Abstract][Full Text] [Related]
2. Monitoring and long-term outcomes in vascularized composite allotransplantation.
Kaufman CL; Ouseph R; Marvin MR; Manon-Matos Y; Blair B; Kutz JE
Curr Opin Organ Transplant; 2013 Dec; 18(6):652-8. PubMed ID: 24220047
[TBL] [Abstract][Full Text] [Related]
3. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
[TBL] [Abstract][Full Text] [Related]
4. The Effect of MHC Antigen Matching Between Donors and Recipients on Skin Tolerance of Vascularized Composite Allografts.
Shanmugarajah K; Powell H; Leonard DA; Mallard C; Albritton A; Harrington E; Randolph MA; Farkash E; Sachs DH; Kurtz JM; Cetrulo CL
Am J Transplant; 2017 Jul; 17(7):1729-1741. PubMed ID: 28035752
[TBL] [Abstract][Full Text] [Related]
5. Vascularized composite allotransplantation: towards tolerance and the importance of skin-specific immunobiology.
Leonard DA; Kurtz JM; Cetrulo CL
Curr Opin Organ Transplant; 2013 Dec; 18(6):645-51. PubMed ID: 24126805
[TBL] [Abstract][Full Text] [Related]
6. Upper extremity and craniofacial vascularized composite allotransplantation: ethics and immunosuppression.
Benedict J; Magill G
Emerg Top Life Sci; 2019 Nov; 3(6):681-686. PubMed ID: 32915212
[TBL] [Abstract][Full Text] [Related]
7. Chronic rejection in vascularized composite allografts.
Mundinger GS; Drachenberg CB
Curr Opin Organ Transplant; 2014 Jun; 19(3):309-14. PubMed ID: 24811439
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of rejection in vascular composite allotransplantation.
Etra JW; Raimondi G; Brandacher G
Curr Opin Organ Transplant; 2018 Feb; 23(1):28-33. PubMed ID: 29189293
[TBL] [Abstract][Full Text] [Related]
9. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.
Plock JA; Schnider JT; Schweizer R; Zhang W; Tsuji W; Waldner M; Solari MG; Marra KG; Rubin JP; Gorantla VS
Transplantation; 2017 Jan; 101(1):e1-e11. PubMed ID: 27893612
[TBL] [Abstract][Full Text] [Related]
10. Novel cell-based strategies for immunomodulation in vascularized composite allotransplantation.
Siemionow M; Kulahci Y; Zor F
Curr Opin Organ Transplant; 2023 Dec; 28(6):431-439. PubMed ID: 37800652
[TBL] [Abstract][Full Text] [Related]
11. The Significance of Vascular Alterations in Acute and Chronic Rejection for Vascularized Composite Allotransplantation.
Kollar B; Kamat P; Klein HJ; Waldner M; Schweizer R; Plock JA
J Vasc Res; 2019; 56(4):163-180. PubMed ID: 31266018
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression maintenance in vascularized composite allotransplantation: what is just right?
Howsare M; Jones CM; Ramirez AM
Curr Opin Organ Transplant; 2017 Oct; 22(5):463-469. PubMed ID: 28759463
[TBL] [Abstract][Full Text] [Related]
13. Premise and promise of mesenchymal stem cell-based therapies in clinical vascularized composite allotransplantation.
Schweizer R; Gorantla VS; Plock JA
Curr Opin Organ Transplant; 2015 Dec; 20(6):608-14. PubMed ID: 26536421
[TBL] [Abstract][Full Text] [Related]
14. Graft vasculopathy of vascularized composite allografts in humans: a literature review and retrospective study.
Ng ZY; Lellouch AG; Rosales IA; Geoghegan L; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
Transpl Int; 2019 Aug; 32(8):831-838. PubMed ID: 30829423
[TBL] [Abstract][Full Text] [Related]
15. Immunopathology of rejection: do the rules of solid organ apply to vascularized composite allotransplantation?
Thaunat O; Badet L; Dubois V; Kanitakis J; Petruzzo P; Morelon E
Curr Opin Organ Transplant; 2015 Dec; 20(6):596-601. PubMed ID: 26536419
[TBL] [Abstract][Full Text] [Related]
16. Large Animal Models of Vascularized Composite Allotransplantation: A Review of Immune Strategies to Improve Allograft Outcomes.
Matar AJ; Crepeau RL; Mundinger GS; Cetrulo CL; Torabi R
Front Immunol; 2021; 12():664577. PubMed ID: 34276656
[TBL] [Abstract][Full Text] [Related]
17. Vascularized composite allotransplantation versus solid organ transplantation: innate-adaptive immune interphase.
Kadono K; Gruszynski M; Azari K; Kupiec-Weglinski JW
Curr Opin Organ Transplant; 2019 Dec; 24(6):714-720. PubMed ID: 31577596
[TBL] [Abstract][Full Text] [Related]
18. Vascularized composite allograft-specific characteristics of immune responses.
Issa F
Transpl Int; 2016 Jun; 29(6):672-81. PubMed ID: 26927941
[TBL] [Abstract][Full Text] [Related]
19. Chronic Rejection in Human Vascularized Composite Allotransplantation (Hand and Face Recipients): An Update.
Kanitakis J; Petruzzo P; Badet L; Gazarian A; Thaunat O; Testelin S; Devauchelle B; Dubernard JM; Morelon E
Transplantation; 2016 Oct; 100(10):2053-61. PubMed ID: 27163543
[TBL] [Abstract][Full Text] [Related]
20. Induction of tolerance of vascularized composite allografts.
Leonard DA; Cetrulo CL; McGrouther DA; Sachs DH
Transplantation; 2013 Feb; 95(3):403-9. PubMed ID: 23114532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
